To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 

Welcome to the FE Ratings homepage. Choose a fund type and a sector, then narrow your search by fund and manager rating, risk score or AFI membership.

 

 

 

 
|
0
   |
50
   |
100
      |
150+
RiskScore

From to

 

Your shortlist – Top 10 results

Rank ChartFund FE Crown Rating FE Alpha Manager FE AFI Constituent FE Risk Score 1y 3y 5y  
1[+]chartPolar Capital Biotechnology R GBPSH
166
70.7n/an/aadd to basket
2[+]chartCandriam Equities L Biotechnology C Cap USD3
180
69.4187.8336.6add to basket
3[+]chartAXA Framlington Biotech R Acc4
184
64.3186.8344.4add to basket
4[+]chartPictet Biotech P dy GBP2
161
61.0132.3230.6add to basket
5[+]chartPolar Capital Healthcare Opportunities R GBP5
113
45.1158.8262.8add to basket
6[+]chartNew Capital China Equity Inst Acc USDSH
179
38.7n/an/aadd to basket
7[+]chartAXA Framlington Health R Acc3
111
36.5101.0163.3add to basket
8[+]chartPictet Health P dy GBP4
110
34.4101.3104.7add to basket
9[+]chartFidelity Global Health Care A GBP2
94
34.392.7129.2add to basket
10[+]chartLindsell Train Japanese Equity B Hedged Dis GBP1
112
33.7137.9n/aadd to basket
Key to codes

LC : Low correlation to benchmarks
SH : Fund with a short history
US : Fund in an unrated sector
PT : Passive fund

Show 3161 more results

All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated on a bid price to bid price basis (mid to mid for OEICs) with net income (dividends) reinvested. Performance figures are shown in Sterling unless otherwise specified.